UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 41

Sortiert nach

Overview of the ethical guidelines for medical and biological research involving human subjects in Japan

Japanese journal of clinical oncology, 2022-05, Vol.52 (6), p.539-544

2022

Volltextzugriff (PDF)

A randomized Phase III trial of adjuvant S-1 therapy vs. observation alone in resected biliary tract cancer: Japan Clinical Oncology Group Study (JCOG1202, ASCOT)

Japanese journal of clinical oncology, 2018-04, Vol.48 (4), p.392-395

2018

Volltextzugriff (PDF)

A randomized Phase III trial of comparing two dose-fractionations stereotactic body radiotherapy (SBRT) for medically inoperable Stage IA non-small cell lung cancer or small lung lesions clinically diagnosed as primary lung cancer: Japan Clinical Oncology Group Study JCOG1408 (J-SBRT trial)

Japanese journal of clinical oncology, 2017-03, Vol.47 (3), p.277-281

2017

Volltextzugriff (PDF)

Randomized Phase III Study of Irinotecan Plus Cisplatin Versus Etoposide Plus Cisplatin for Completely Resected High-Grade Neuroendocrine Carcinoma of the Lung: JCOG1205/1206

Journal of clinical oncology, 2020-12, Vol.38 (36), p.4292-4301

2020

Volltextzugriff (PDF)

A randomized phase III trial of denosumab before curettage for giant cell tumor of bone: Japan Clinical Oncology Group Study JCOG1610

Japanese journal of clinical oncology, 2019-04, Vol.49 (4), p.379-382

2019

Volltextzugriff (PDF)

Randomized phase III study to evaluate the value of omission of prophylactic neck dissection for stage I/II tongue cancer: Japan Clinical Oncology Group study (JCOG1601, RESPOND)

Japanese journal of clinical oncology, 2018-12, Vol.48 (12), p.1105-1108

2018

Volltextzugriff (PDF)

Impact of Previous, Simultaneous or Subsequent Bladder Cancer on Prognosis after Radical Nephroureterectomy for Upper Urinary Tract Urothelial Carcinoma

The Journal of urology, 2019-12, Vol.202 (6), p.101097JU0000000000000422-1135

2019

Volltextzugriff (PDF)

Nutritional support dependence after curative chemoradiotherapy in head and neck cancer: supplementary analysis of a phase II trial (JCOG0706S1)

Japanese journal of clinical oncology, 2019-12, Vol.49 (11), p.1009-1015

2019

Volltextzugriff (PDF)

A Phase III study of oral steroid administration versus local steroid injection therapy for the prevention of esophageal stricture after endoscopic submucosal dissection (JCOG1217, Steroid EESD P3)

Japanese journal of clinical oncology, 2015-11, Vol.45 (11), p.1087-1090

2015

Volltextzugriff (PDF)

Significance of the timing of ureteral ligation on prognosis during radical nephroureterectomy for upper urinary tract urothelial cancer

International journal of urology, 2021-02, Vol.28 (2), p.208-214

2021

Volltextzugriff (PDF)

Dose‐finding and efficacy confirmation trial of the superselective intra‐arterial infusion of cisplatin and concomitant radiotherapy for locally advanced maxillary sinus cancer (Japan Clinical Oncology Group 1212): Dose‐finding phase

Head & neck, 2018-03, Vol.40 (3), p.475-484

2018

Volltextzugriff (PDF)

A Phase III trial of a single early intravesical instillation of pirarubicin to prevent bladder recurrence after radical nephroureterectomy for upper tract urothelial carcinoma (JCOG1403, UTUC THP Phase III)

Japanese journal of clinical oncology, 2018-01, Vol.48 (1), p.94-97

2018

Volltextzugriff (PDF)

Results from a 1-day workshop on the assessment of quality of life in cancer patients: a joint initiative of the Japan Clinical Oncology Group and the European Organisation for Research and Treatment of Cancer

Japanese journal of clinical oncology, 2020-11, Vol.50 (11), p.1333-1341

2020

Volltextzugriff (PDF)

Role of lymph node dissection during radical nephroureterectomy for upper urinary tract urothelial cancer: multi-institutional large retrospective study JCOG1110A

World journal of urology, 2017-11, Vol.35 (11), p.1737-1744

2017

Volltextzugriff (PDF)

Stereotactic body radiotherapy versus lobectomy for operable clinical stage IA lung adenocarcinoma: comparison of survival outcomes in two clinical trials with propensity score analysis (JCOG1313-A)

Japanese journal of clinical oncology, 2016-08, Vol.46 (8), p.748-753

2016

Volltextzugriff (PDF)

A Phase III trial comparing irinotecan and cisplatin with etoposide and cisplatin in adjuvant chemotherapy for completely resected pulmonary high-grade neuroendocrine carcinoma (JCOG1205/1206)

Japanese journal of clinical oncology, 2014-04, Vol.44 (4), p.379-382

2014

Volltextzugriff (PDF)

Conducting specified clinical trials under the Japanese clinical trials act

Rinshō ketsueki, 2020, Vol.61 (9), p.1007

Eba, Junko

2020

Volltextzugriff (PDF)

A randomized controlled Phase II/III study comparing endoscopic balloon dilation combined with steroid injection versus radial incision and cutting combined with steroid injection for refractory anastomotic stricture after esophagectomy: Japan Clinical Oncology Group Study JCOG1207

Japanese journal of clinical oncology, 2015-04, Vol.45 (4), p.385-389

2015

Volltextzugriff (PDF)

A Phase II/III study comparing carboplatin and irinotecan with carboplatin and etoposide for the treatment of elderly patients with extensive-disease small-cell lung cancer (JCOG1201)

Japanese journal of clinical oncology, 2015-01, Vol.45 (1), p.115-118

2015

Volltextzugriff (PDF)

Reply to J. L. Derks et al

Journal of clinical oncology, 2021-05, Vol.39 (13), p.1509-1510

2021

Volltextzugriff (PDF)

A randomized phase II/III study comparing carboplatin and irinotecan with carboplatin and etoposide for the treatment of elderly patients with extensive-disease small cell lung cancer (JCOG1201/TORG1528)

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.8571-8571

2021

Volltextzugriff (PDF)

Evaluation of value in non-inferiority trials by ASCO’s conceptual framework

Journal of clinical oncology, 2016-05, Vol.34 (15_suppl), p.e18276-e18276

2016

Volltextzugriff (PDF)

Second primary cancers and recurrence in patients after resection of colorectal cancer: An integrated analysis of trials by Japan Clinical Oncology Group: JCOG0205, JCOG0212, JCOG0404 (JCOG1702A)

Journal of clinical oncology, 2018-02, Vol.36 (4_suppl), p.561-561

2018

Volltextzugriff (PDF)

The role of adjuvant chemotherapy for pT2-4 upper urinary tract urothelial cancer: Exploratory analysis of large multi-institutional study (JCOG1110A)

Journal of clinical oncology, 2019-03, Vol.37 (7_suppl), p.374-374

2019

Volltextzugriff (PDF)

Surrogacy of progression-free survival (PFS) for overall survival (OS) in esophageal cancer (EC) trials with preoperative therapy (PreTx): Literature-based meta-analysis

Journal of clinical oncology, 2015-01, Vol.33 (3_suppl), p.199-199

2015

Volltextzugriff (PDF)

1 – 25 von 41

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(30)
Mit Volltextzugriff
(39)

Publikationsform

Artikel
(31)
Bücher
(10)

Sprache

Englisch
(40)
Japanisch
(13)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(19)
Science & Technology
(19)
Oncology
(16)
Japan
(15)
Humans
(14)
Female
(11)
Male
(11)
Aged
(9)
Middle Aged
(9)
Adult
(6)
Phase Iii
(6)
Social Sciences
(5)
History
(4)
Neoplasm Staging
(4)
Prognosis
(4)
Treatment Outcome
(4)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(3)
Cancer
(3)
Historia
(3)
Lung Neoplasms - Drug Therapy
(3)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Overview of the ethical guidelines for medical and biological research involving human subjects in Japan

A randomized Phase III trial of adjuvant S-1 therapy vs. observation alone in resected biliary tract cancer: Japan Clinical Oncology Group Study (JCOG1202, ASCOT)

A randomized Phase III trial of comparing two dose-fractionations stereotactic body radiotherapy (SBRT) for medically inoperable Stage IA non-small cell lung cancer or small lung lesions clinically diagnosed as primary lung cancer: Japan Clinical Oncology Group Study JCOG1408 (J-SBRT trial)

Randomized Phase III Study of Irinotecan Plus Cisplatin Versus Etoposide Plus Cisplatin for Completely Resected High-Grade Neuroendocrine Carcinoma of the Lung: JCOG1205/1206

A randomized phase III trial of denosumab before curettage for giant cell tumor of bone: Japan Clinical Oncology Group Study JCOG1610

Randomized phase III study to evaluate the value of omission of prophylactic neck dissection for stage I/II tongue cancer: Japan Clinical Oncology Group study (JCOG1601, RESPOND)

Impact of Previous, Simultaneous or Subsequent Bladder Cancer on Prognosis after Radical Nephroureterectomy for Upper Urinary Tract Urothelial Carcinoma

Nutritional support dependence after curative chemoradiotherapy in head and neck cancer: supplementary analysis of a phase II trial (JCOG0706S1)

A Phase III study of oral steroid administration versus local steroid injection therapy for the prevention of esophageal stricture after endoscopic submucosal dissection (JCOG1217, Steroid EESD P3)

Significance of the timing of ureteral ligation on prognosis during radical nephroureterectomy for upper urinary tract urothelial cancer

Dose‐finding and efficacy confirmation trial of the superselective intra‐arterial infusion of cisplatin and concomitant radiotherapy for locally advanced maxillary sinus cancer (Japan Clinical Oncology Group 1212): Dose‐finding phase

A Phase III trial of a single early intravesical instillation of pirarubicin to prevent bladder recurrence after radical nephroureterectomy for upper tract urothelial carcinoma (JCOG1403, UTUC THP Phase III)

Results from a 1-day workshop on the assessment of quality of life in cancer patients: a joint initiative of the Japan Clinical Oncology Group and the European Organisation for Research and Treatment of Cancer

Role of lymph node dissection during radical nephroureterectomy for upper urinary tract urothelial cancer: multi-institutional large retrospective study JCOG1110A

Stereotactic body radiotherapy versus lobectomy for operable clinical stage IA lung adenocarcinoma: comparison of survival outcomes in two clinical trials with propensity score analysis (JCOG1313-A)

A Phase III trial comparing irinotecan and cisplatin with etoposide and cisplatin in adjuvant chemotherapy for completely resected pulmonary high-grade neuroendocrine carcinoma (JCOG1205/1206)

Conducting specified clinical trials under the Japanese clinical trials act

A randomized controlled Phase II/III study comparing endoscopic balloon dilation combined with steroid injection versus radial incision and cutting combined with steroid injection for refractory anastomotic stricture after esophagectomy: Japan Clinical Oncology Group Study JCOG1207

A Phase II/III study comparing carboplatin and irinotecan with carboplatin and etoposide for the treatment of elderly patients with extensive-disease small-cell lung cancer (JCOG1201)

Reply to J. L. Derks et al

A randomized phase II/III study comparing carboplatin and irinotecan with carboplatin and etoposide for the treatment of elderly patients with extensive-disease small cell lung cancer (JCOG1201/TORG1528)

Evaluation of value in non-inferiority trials by ASCO’s conceptual framework

Second primary cancers and recurrence in patients after resection of colorectal cancer: An integrated analysis of trials by Japan Clinical Oncology Group: JCOG0205, JCOG0212, JCOG0404 (JCOG1702A)

The role of adjuvant chemotherapy for pT2-4 upper urinary tract urothelial cancer: Exploratory analysis of large multi-institutional study (JCOG1110A)

Surrogacy of progression-free survival (PFS) for overall survival (OS) in esophageal cancer (EC) trials with preoperative therapy (PreTx): Literature-based meta-analysis

Suchergebnisse filtern